Douglas L. Braunstein, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 11,738 shares at $62.63 ($716K) on 2019-10-15, disclosed to the SEC on 2019-10-15.
Scheduled sale ($716k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.16 | 7,829 | $471K | 65.8% |
| 2 | $62.63 | 3,909 | $245K | 34.2% |
| Total | $60.98 avg | 11,738 | $716K | 100% |
| Filing → |
| TALK | BUY | 2021-06-24 | $50.0M | — | Filing → |
| HCII | SELL | 2021-04-14 | $0 | — | Filing → |
| EGRX | SELL | 2019-09-19 | $6K | — | Filing → |